FolioLanternBeta
RMDResMed|

Brett Sandercock

Chief Financial Officer at ResMed|, as of May 4, 2026Sold $2.0M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
83K
shares held after the latest filing, ResMed|
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
8K
shares sold, past 12 months
6
days with sales
$743K
largest single day, Nov 3, 2025
1
company filed for

Share of stake sold at ResMed| is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $743K under a disclosed plan$743KNovDec 2025: $244K under a disclosed planDecJan 2026: $242K under a disclosed planJanFeb 2026: $257K under a disclosed planFebMar 2026: $254K under a disclosed planMarApr 2026: $224K under a disclosed planAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
ResMed| (RMD)Chief Financial OfficerDec 5, 2005May 4, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.